Related references
Note: Only part of the references are listed.Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations
Robert L. Atmar et al.
CLINICAL INFECTIOUS DISEASES (2006)
Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine:: phase I randomised trial
Jean-Louis Bresson et al.
LANCET (2006)
Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine
JJ Treanor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Avian influenza A (H5N1) in 10 patients in Vietnam.
TT Hien et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine
I Stephenson et al.
VIRUS RESEARCH (2004)
From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza
JM Wood et al.
NATURE REVIEWS MICROBIOLOGY (2004)
Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adults
S Frey et al.
VACCINE (2003)
Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza
KG Nicholson et al.
LANCET (2001)
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
JJ Treanor et al.
VACCINE (2001)
Share Paper
